DS
RXRX icon

DRW Securities’s Recursion Pharmaceuticals RXRX Stock Holding History

DRW Securities’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$87.6K Buy
+28,520
New +$110K ﹤0.01% 1190
2025
Q4 		– Sell
-41,409
Closed -$203K – 1631
2025
Q3 		$203K Buy
41,409
+24,812
+149% +$130K ﹤0.01% 1072
2025
Q2 		$84K Buy
+16,597
New +$81.5K ﹤0.01% 1027

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

DRW Securities's RXRX Position: Q1 2026 in Review

DRW Securities opened a new position in Recursion Pharmaceuticals (RXRX) in Q1 2026: 28,520 shares worth $87.6K. The stake represents ﹤0.01% of the portfolio and ranks #1190 among its holdings. This is a return to the name: DRW Securities previously reported a position in RXRX as recently as Q3 2025.

DRW Securities first reported a position in RXRX in Q2 2025 and has held it in 3 quarters since. The position peaked at $203K in Q3 2025. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • DRW Securities held 28,520 shares of Recursion Pharmaceuticals worth $87.6K as of Q1 2026.
  • Recursion Pharmaceuticals was a new DRW Securities position in Q1 2026.
  • Recursion Pharmaceuticals made up ﹤0.01% of DRW Securities's portfolio in Q1 2026, its #1190 holding.
  • DRW Securities first reported a position in Recursion Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • DRW Securities's Recursion Pharmaceuticals position peaked at $203K in Q3 2025.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.